The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1 agonists for weight loss skyrockets, according to data from Gallup.

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped, an encouraging sign that America’s epidemic of excess weight might be improving. But ...

As Health Secretary Robert F. Kennedy Jr. says he is looking at addressing the issues driving the U.S. “obesity epidemic” in his attempt to make America “healthy again,” new data reveals that the ...

The obesity rate in the U.S. dropped to 37% this year, representing a notable decrease after reaching a record high of 39.9% in 2022, according to data from Gallup. The decline may be in part due to ...

The prevalence of obesity in the United States could rise sharply under a definition of obesity released earlier this year by the Lancet Diabetes and Endocrinology Commission. Additionally, the ...

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention ...

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped, an encouraging sign that America’s epidemic of excess weight might be improving. But ...